Virios Therapeutics Llc Buy Hold or Sell Recommendation

VIRIDelisted Stock  USD 3.95  0.00  0.00%   
Given the investment horizon of 90 days and your below-average risk tolerance, our recommendation regarding Virios Therapeutics Llc is 'Not Rated'. The recommendation algorithm takes into account all of Virios Therapeutics' available fundamental, technical, and predictive indicators you will find on this site.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
In addition, we conduct extensive research on individual companies such as Virios and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Virios Therapeutics Llc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Execute Virios Therapeutics Buy or Sell Advice

The Virios recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Virios Therapeutics Llc. Macroaxis does not own or have any residual interests in Virios Therapeutics Llc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Virios Therapeutics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Virios TherapeuticsBuy Virios Therapeutics
Not Rated
For the selected time horizon Virios Therapeutics Llc has a Risk Adjusted Performance of (0.02), Jensen Alpha of (0.38), Total Risk Alpha of (1.78) and Treynor Ratio of (1.38)
We provide advice to complement the current expert consensus on Virios Therapeutics. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure Virios Therapeutics Llc is not overpriced, please validate all Virios Therapeutics fundamentals, including its book value per share, as well as the relationship between the number of employees and working capital . Given that Virios Therapeutics Llc has a number of shares shorted of 469.93 K, we advise you to double-check Virios Therapeutics Llc market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your current risk tolerance and investing horizon.

Virios Therapeutics Trading Alerts and Improvement Suggestions

Virios Therapeutics is now traded under the symbol DWTX. Please update your portfolios or report it if you believe this is an error. Report It!
Virios Therapeutics is not yet fully synchronised with the market data
Virios Therapeutics had very high historical volatility over the last 90 days
Virios Therapeutics has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (5.3 M) with profit before overhead, payroll, taxes, and interest of 0.
Virios Therapeutics Llc currently holds about 7.7 M in cash with (4.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.92.

Virios Therapeutics Returns Distribution Density

The distribution of Virios Therapeutics' historical returns is an attempt to chart the uncertainty of Virios Therapeutics' future price movements. The chart of the probability distribution of Virios Therapeutics daily returns describes the distribution of returns around its average expected value. We use Virios Therapeutics Llc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Virios Therapeutics returns is essential to provide solid investment advice for Virios Therapeutics.
Mean Return
-0.34
Value At Risk
-10.62
Potential Upside
12.46
Standard Deviation
8.56
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Virios Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Acquisition by Whitley Richard James of 5250 shares of Virios Therapeutics at 1.85 subject to Rule 16b-3 [view details]

Virios Therapeutics Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Virios . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Virios Therapeutics Buy or Sell Advice

When is the right time to buy or sell Virios Therapeutics Llc? Buying financial instruments such as Virios Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Virios Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Business Supplies Thematic Idea Now

Business Supplies
Business Supplies Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Business Supplies theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Business Supplies Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Consideration for investing in Virios Stock

If you are still planning to invest in Virios Therapeutics Llc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Virios Therapeutics' history and understand the potential risks before investing.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance